FDA Grants Full Approval To Pfizer COVID-19 Vaccine
This illustration picture taken on November 23, 2020 shows a bottle reading "Vaccine Covid-19" and a syringe next to the Pfizer and Biontech logo. - The European Commission has signed five contracts to pre-order vaccines, among which with the U.S.-German company Pfizer-BioNTech (up to 300 million doses). (Photo by JOEL SAGET / AFP) (Photo by JOEL SAGET/AFP via Getty Images)

The FDA has officially granted full approval to Pfizer’s COVID-19 vaccine.

The move was announced Monday morning after a three-month review of the company’s application.

The vaccine will now be marketed as ‘Comirnaty’, and is approved for all people 16 and older.  It will remain under emergency authorization for children ages 12-15.

So what does full approval mean?  Possibly more vaccine mandates from employers and universities, who were waiting for full approval to require vaccinations.

It could also mean more people getting the shot – a recent poll found that 30 percent of unvaccinated people would be more willing to take a vaccine that had full FDA approval.

Why did it the approval process take so long?  Do you think it will have a big impact on vaccination rates?

More about: